Form 4: Guardant Health Director Acquires Shares

Guardant Health Director Musa Tariq acquired 250 shares of common stock through the exercise of restricted stock units on December 15, 2025.

Summary

• Musa Tariq, a Director of Guardant Health, Inc. (GH), acquired 250 shares of common stock.
• The transaction occurred on December 15, 2025, and was an exercise or conversion of derivative securities (Restricted Stock Units) at a price of $0.
• Following this transaction, Musa Tariq directly beneficially owns 8,109 shares of common stock.
• The Restricted Stock Units were granted on March 6, 2023, with 25% vesting on March 15, 2024, and the remaining 75% vesting monthly over the subsequent three years.
• After this transaction, Musa Tariq directly beneficially owns 3,748 Restricted Stock Units.

Sentiment

Score: 6

Explanation: A routine insider acquisition through RSU vesting, which is a neutral event but slightly positive as it increases director's direct ownership, signaling continued alignment with shareholder interests.

Positives

• A director acquiring shares, even through vesting, can signal continued confidence in the company's future.
• The transaction was made pursuant to a Rule 10b5-1 plan, indicating a pre-scheduled, non-discretionary transaction.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing is a routine insider transaction report and does not provide specific insights into broader industry trends or competitive landscape.

Related Party Transactions

• The acquisition of shares by Director Musa Tariq through the vesting of Restricted Stock Units is a transaction between the company and a related party (an insider). This is a standard component of executive and director compensation.

Stakeholder Impact

• Shareholders: The increase in direct beneficial ownership by a director may be viewed positively as it aligns management interests with shareholder interests.
• Employees: No direct impact on employees is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.
• Suppliers: No direct impact on suppliers is indicated by this filing.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• Continued monthly vesting of the remaining 3,748 Restricted Stock Units over the next three years from March 15, 2024.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-scheduled vesting and acquisition of shares by a director. It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. It primarily confirms an expected increase in insider ownership.

Keywords

Guardant Health, GH, Musa Tariq, Director, Insider transaction, Form 4, Restricted Stock Units, Stock acquisition, 10b5-1 plan, Beneficial ownership